Skip to main content

Table 5 Logistic regression analysis of preoperative factors in patients with and without diabetes remission 1-year after surgery

From: Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study

Characteristic

Unadjusted OR (95% CI)

p-value

Adjusted OR (95% CI) *

p-value

Female (male = ref)

0.79 (0.57–1.12)

0.194

0.68 (0.45–1.02)

0.064

Age on day of surgery (for each year)

0.95 (0.94–0.96)

< 0.001

0.97 (0.95–0.98)

< 0.001

BMI (kg/m2) (for each 1 unit)

1.05 (1.03–1.08)

< 0.001

1.04 (1.01–1.07)

0.003

Diabetes duration (for each year)

0.86 (0.84–0.88)

< 0.001

0.92 (0.89–0.94)

< 0.001

Insulin use

0.16 (0.12–0.22)

< 0.001

0.28 (0.19–0.42)

< 0.001

Number of oral antidiabetic medications before surgery

    

 0

 1

 2

 ≥3

1

1.11 (0.59–2.09)

1.04 (0.47–2.29)

0.45 (0.15–1.31)

0.739

0.923

0.141

1

1.06 (0.58–1.94)

0.96 (0.45–2.07)

0.58 (0.15–2.17)

0.857

0.924

0.418

Type of surgeries

    

RYGB

OAGB

SG

1

0.93 (0.68–1.26)

0.76 (0.51–1.13)

0.642

0.173

1

0.84 (0.58–1.22)

0.79 (0.48–1.30)

0.354

0.357

Fasting blood sugar (mg/dl) (for each 1 mg/dl)

0.99 (0.98–0.99)

< 0.001

0.995 (0.991–0.998)

0.001

HbA1c (for each 1%)

0.64 (0.59–0.69)

< 0.001

0.78 (0.69–0.87)

< 0.001

Total cholesterol (mg/dl)

1.00 (0.995–1.01)

0.835

1.003 (0.995–1.012)

0.445

Triacylglycerol (mg/dl)

1.00 (0.999–1.001)

0.763

0.998 (0.997-1.00)

0.084

HDL-cholesterol (mg/dl)

1.001 (0.989–1.014)

0.852

1.00 (0.998–1.002)

0.997

LDL- cholesterol (mg/dl)

0.999 (0.995–1.002)

0.410

0.995 (0.986–1.004)

0.282

AST (IU/L)

0.997 (0.99–1.004)

0.391

1.00 (0.986–1.013)

0.943

ALT (IU/L)

0.998 (0.99–1.01)

0.265

0.998 (0.988–1.008)

0.674

Systolic blood pressure, mm Hg

0.999 (0.991–1.007)

0.843

1.006 (0.992–1.019)

0.423

Diastolic blood pressure, mm Hg

1.003 (0.989–1.016)

0.707

0.996 (0.974–1.018)

0.725

Obesity-related disease (no = ref)

    

Dyslipidemia

Hypertension

Cardiovascular Disease

Hypothyroidism

Sleep Apnea

Asthma

Fatty Liver

1.06 (0.81–1.39)

1.02 (0.78–1.34)

1.11 (0.82–1.50)

0.83 (0.62–1.11)

0.83 (0.62–1.09)

1.42 (0.86–2.36)

0.96 (0.67–1.40)

0.667

0.869

0.512

0.215

0.187

0.173

0.839

1.13 (0.79–1.60)

1.04 (0.73–1.47)

1.15 (0.76–1.72)

0.69 (0.48–1.02)

0.84 (0.58–1.21)

1.76 (0.94–3.32)

1.21 (0.76–1.93)

0.504

0.834

0.508

0.168

0.339

0.079

0.417

Family History of, (no = ref)

    

Obesity

Hypertension

Diabetes

Dyslipidemia

Fatty Liver

0.42 (0.26–0.68)

1.34 (0.76–2.36)

0.75 (0.55–1.02)

0.90 (0.12–6.86)

1.14 (0.45–2.88)

< 0.001

0.317

0.064

0.919

0.790

0.33 (0.19–0.56)

1.72 (0.82–3.64)

0.95 (0.65–1.39)

0.60 (0.12–3.01)

1.03 (0.44–1.78)

< 0.001

0.154

0.813

0.537

0.731

  1. * Multivariable logistic regression including all factors listed in the table